Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04151667
Title Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

multiple myeloma

Therapies

Daratumumab + Dexamethasone

Bortezomib + Daratumumab + Dexamethasone

Daratumumab + Dexamethasone + Lenalidomide

Age Groups: senior
Covered Countries USA


No variant requirements are available.